The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

"Providing access to quality care for our Medicare Advantage members with complex health conditions is crucial," said Alan Stewart, President of Humana's Medicare East Division. "Our collaboration ...

Kidney disease, leading to kidney failure, afflicts disproportionately more black people than white people. Thus, there is a huge burden of kidney healthcare costs among black people all over the ...

Kidney disease, leading to kidney failure, afflicts disproportionately more black people than white people. Thus, there is a huge burden of kidney healthcare costs among black people all over the ...